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Abstract
Background: Allium sativum L. (A.S.) “garlic”, one of the most interesting medicinal plants, has been suggested to
contain compounds that could be beneficial in numerous pathological situations including cancer. In this work, we
aimed to assess the immunomodulatory effect of A.S. preparation on human peripheral blood mononuclear cells
from healthy individuals.
Methods: Nontoxic doses of A.S. were identified using MTT assay. Effects on CD4+ or CD8+ T lymphocyte
proliferation were studied using flow cytometry. The effect of A.S. on cytokine gene expression was studied using
qRT-PCR. Finally, qualitative analysis of A.S. was performed by HPLC approach. Data were analyzed statistically by
one-way ANOVA test.
Results: The nontoxic doses of A.S. preparation did not affect neither spontaneous nor TCR-mediated CD4+ or
CD8+ T lymphocyte proliferation. Interestingly, A.S. exhibited a statistically significant regulation of IL-17 gene
expression, a cytokine involved in several inflammatory and autoimmune diseases. In contrast, the expression of
IL-4, an anti-inflammatory cytokine, was unaffected. Qualitative analysis of A.S. ethanol preparation indicated the
presence of three polyphenol bioactive compounds, which are catechin, vanillic acid and ferulic acid.
Conclusion: The specific inhibition of the pro-inflammatory cytokine, IL-17 without affecting cell proliferation in
human PBMCs by the Allium sativum L. preparation suggests a potential valuable effect of the compounds present
in this plant for the treatment of inflammatory diseases and cancer, where IL-17 is highly expressed. The individual
contribution of these three compounds to this global effect will be assessed.
Keywords: Allium sativum, Peripheral blood mononuclear cells, Anti-inflammation, Cytokines, Gene expression,
Cell proliferation, Cell toxicity
Background
T cells represent about 70 % of human Peripheral Blood
Mononuclear Cells (PBMCs), in addition to monocytes,
natural killer “NK” cells and B cells. Among T lympho-
cytes, CD4+ T cells are subdivided into various subpopu-
lations such as Th1, Th2 and Th17 cells. Each of these
subpopulations has its own set of immunological
functions, allowed by a specific group of produced cyto-
kines. For instance, Th1 cells are in charge of intracellu-
lar pathogen eradication [1, 2]; but are also involved
in the progress of autoimmune diseases and chronic
inflammatory disorders [3]. They are characterized by
high secretion of IFN-γ and IL-2. Th2 cells are implicated
in humoral immunity and provide protection against
parasites. They are engaged in human allergic inflamma-
tion; its initiation, maintenance and amplification [4]
via the production of IL-4, IL-10 and IL-13 [4, 5]. Th17
are involved in the clearance of extracellular bacteria and
fungi, due to their capacity to recruit and activate
Neutrophils [6]. They are known for their production
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of IL-17A and IL-17 F. However, Th17 cells are also
implicated in promoting the pathogenesis of cancer [7],
several autoimmune and inflammatory diseases [8]; such
as rheumatoid arthritis, multiple sclerosis, inflammatory
bowel disease, psoriasis and contact dermatitis [9, 10].
Our main interest is to identify phyto-molecules capable
of regulating specific pro-inflammatory cytokines such as
IL-17, which is implicated in various pathological situa-
tions including autoimmunity [8] and cancer [7, 9, 10].
Allium sativum L., a member of the Liliaceae family, is
used universally as a flavoring agent in traditional medi-
cine and to enhance physical and mental health [11–15].
Some reports also showed that a protein fraction of aged
A.S. extract enhanced NK cell activity and cytotoxicity
of macrophages towards tumor cells [16]. Another study
demonstrated that ingestion of A.S. oil modulated the
production of T helper cytokines in rat cervical lymph
nodes [17]. Accordingly, A.S. and its specific ingredients,
organosulphur compounds, are thought to affect the
immune system [18].
In this paper, we aimed to assess the immunomodula-
tory effect of A.S. extract on human peripheral blood
mononuclear cells. Doses of A.S., which did not cause
cytotoxicty and did not affect cell proliferation, exhibited
a marked regulation of the expression of the pro-
inflammatory cytokine IL-17, known to be involved in
numerous autoimmune and inflammatory diseases.
Methods
A.S. extract preparation
Allium sativum L. “garlic” bulbs were harvested from a
botanical garden in the Faculty of Medicine and Phar-
macy of Casablanca, Morocco. The plant was identified
by a professor of Botany affiliated to the Biology depart-
ment of the Polydisciplinary Faculty of Safi. A voucher
of the plant specimen has been deposited in the herbar-
ium of the department of Botany of the Scientific Insti-
tute of Rabat, Morocco under the reference number
97997. One-hundred grams of peeled dry garlic bulbs
were mashed and incubated in ethanol (Sigma, USA) for
24 h (twice) at room temperature. Extracts were then
concentrated by rotary. The obtained ethanolic extracts
were stored at -20C° until use.
Analysis of polyphenols by HPLC
Qualitative analysis of standard phenolic compounds in
A.S. ethanolic extract was performed using high per-
formance liquid chromatography (HPLC) type JASCO
PU-1580, equipped with a UV detector / Vis type JASCO
875 UV and a data treatment station Azur version
3.0.3.0. The extract was evaporated to dryness at 40 °C
and then taken up with a mixture of distilled water -
acetonitril (88–12 %). After vigorous stirring, mixtures
were filtered by passing the solution through Whattman
nylon membrane. Analysis conditions used were: Column:
C18 (1.7 μm 2,1 × 150 mm), UV Wavelength: 285 nm,
1 ml / min, gradient elution program was set as water
/acetonitrile (88–12 %). The solution of the polyphenol
mixture: Catechin, rutin, vanillin, vanillic acid, caffeic acid,
syringic acid and ferulic acid was prepared by dissolving
1–5 mg of each polyphenol in 1 ml of the acetonitril -
water 12–88 %. The final solution was filtered through a
Whattman nylon membrane 0.22 μm.
PBMC preparation and cell culture
Peripheral blood mononuclear cells “PBMCs” were sepa-
rated from fresh venous blood collected from healthy
donors as previously described [19]. PBMCs isolation
was performed by centrifugation on Ficoll- histopaque
1077 (Sigma, USA), at 900 g for 25 min at 18–20 °C, then
washed three times by centrifugation, and suspended in
RPMI 1640 media (sigma, USA) with L-glutamine supple-
mented with 10 % heat inactivated newborn calf serum
(sigma, USA), 26.3 g/l penicillin and 4.2 g/l streptomycin.
Cells were counted using a hemocytometer and standard
Trypan blue exclusion method and observed under
microscopy. Cells were harvested in plat culture at 37 °C
in a humid atmosphere containing 5 % CO2 (Heracell 150i
incubator CO2, Thermosciences, France) with different
doses of A.S. preparation, with or without 5 μg/ml of
phytohaemagglutinin (PHA; Sigma, USA) or plat bound
monoclonal anti-CD3 (Okt3, 0.1 μg/ml).
MTT assay
Cytotoxicity of A.S. extract to PBMCs was evaluated by
MTT (3-(4, 5 dimethylthiazol-2-yl)-2, 5 diphenyltetrazo-
lium bromide) assay [19, 20]. The test was performed in
96-well plates (Hiwaka, Japan). Triplicate cultures in
200 μl of cell suspension (105cells/well) were incubated
in the presence of different doses of A.S. extract with or
without stimulation using PHA or anti-human CD3
Okt3 monoclonal Ab. After 4 days of culture, 20 μl of
MTT solution (5 mg/ml, Sigma, USA) was added to the
wells and incubated for additional 4 h under the same
conditions. After removing the plates and centrifuging
them at 800 × g for 20 min, supernatant was removed
and blue formazan crystals were solubilized by adding
100 μl of DMSO (Sigma, USA) under agitation. Optical
Density of cells with A.S. extract was compared to that
of control cells. Low optical density readings reflected
low coloration intensity, due to the inability of non-
viable cells to metabolize MTT salts.
Proliferation assay
PBMCs (106cell/ml) were harvested in 96-well plates.
A.S. extract was used at final concentrations of 1 and
2 μg/ml, with or without PHA and with or without anti-
CD3 (Okt-3). Cells were labeled before culture with 5,
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6-carboxyfluorescein diacetate succinimidyl ester (CFSE)
(Sigma, USA) at a concentration of 5 μM, according to a
previous paper [21]. Afterward, labeled cells were washed
twice with RPMI containing 5 % heat inactivated newborn
calf serum. After 4 days of culture, PBMCs were labeled
with Anti-CD4 (PrCP, BDBiosciences, France) and anti-
CD8 (APC BD Biosciences, France), in order to evaluate
proliferation of CD4+ and CD8+ lymphocyte subsets.
Analyses were performed using FACS (BD FACSCalibur
Flow Cytometer, BD Biosciences, France) and FlowJo
software (Ashland, USA). One hundred thousand events
were analyzed per sample.
Gene expression quantification by RT-qPCR
Total RNA isolation
TRIzol (Sigma, France) was used to isolate total ARN
from cells cultured for 18 h with different doses of A.S.
extract in the presence or absence of PHA. Isolated
RNA was solubilized in DEPC Treated Water (Invitro-
gene, France) and measured with spectrophotometer
(NanoVue™ Plus Spectrophotometer GE Healthcare UK
Limited, UK).
Reverse Transcription (RT)
0.5 μg of total ARN was used to synthesize cDNA using
M-MLV reverse transcriptase (Reverse Transcriptase
Super Scripte III, 10000 units, Invitrogene, France) in a
20 μl reaction mixture according to the manufacturer’s
instructions. 1 μl of oligo dT20 (50 μM) and 1 μl of
dNTP (10 mM of each) were added and the mixture was
incubated at 65 °C for 5 min to break the secondary
structure of RNA; and then put on ice for 5 min. 4 μl of
5X Reverse Transcriptase buffer, 1 μl de DTT (100 mM),
1 μl of RNase Inhibitor (RNasin OUT 5000 units, Invi-
trogene, France) and 1 μl of M-MLV reverse transcript-
ase were subsequently added and the mixture was
incubated at 50 °C for 60 min, then 70 °C for 15 min.
Real-time PCR assays
Amplifications were performed using Syber® Green PCR
Master mix (Applied Biosystems™, life Technologies,
France) as recommended by the manufacturer’s manual.
Using primers at 500nM for all genes, PCR was pro-
grammed as follows: 10 min at 95 °C for polymerase
activation and sample denaturation; then 40 cycles of
15 s at 95 °C and 60 s at 60 °C for annealing and exten-
sion. Relative quantification of gene expression was ana-
lyzed by real-time PCR using real time Fast 7500 (Applied
Biosystems™). β-actin was used as internal control. Primers
used are as follows; β-actin: forward GAGATGGCC
ACGGCTGCTT, reverse GCCACAGGACTCCATGC
CCA (transcript size: 446 bp), IL-17: forward ATCTC
CACCGCAATGAGGAC, reverse: GTGGACAATCGG
GGTGACAC (transcript size: 77 bp), IL-4: forward ATG
GGTCTCACCTCCCAACTGCT, reverse GTTTTCCAA
CGTACTCTGGTTGGC (transcripts size: 506, 357, 405 bp)
and IFN-γ forward GAAGAATTGGAAAGAGGA, reverse
CGACAGTTCAGCCATCAC (transcript size: 265 bp).
Fluorescence readings at the end of the extension phase
of each cycle were used to estimate the values for the
threshold cycles (Ct). The Ct values for each gene were
converted into relative quantification (2-ΔΔCt) using the
machine 7500 v2.0.6 software. Samples of untreated and
unstimulated cells were used as a calibrator for unstimu-
lated treated cells samples. On the other hand, untreated
stimulated samples were used as a calibrator for stimu-
lated and treated cell samples. PCR negative control
(with no template) was included for each pair of primers.
Statistical analysis
All data were expressed as means +/− standard devia-
tions. Groups were compared using one-way ANOVA
followed by Bonferroni’s Multiple Comparison test, with
a level of significance set at p < 0.05. GraphPad Prism 5.0
software was used for all statistical analyses.
Results
Evaluation of the cytotoxicity of Allium sativum
preparation to human PBMCs
In order to assess the immunomodulatory effect of the
A.S. preparation, we started by evaluating cell toxicity
of different doses of A.S.. Human PBMCs were treated
with increasing doses of A.S. extract in the presence
or the absence of stimulation (PHA or anti-CD3 mAb).
Figure 1a shows that A.S. extract was not toxic to PBMCs
at doses ranging between 0.5 and 4 μg/ml. On the other
hand, A.S. extract was found not toxic to PBMCs stimu-
lated with PHA up to certain doses (0.5 to 2 μg/ml). How-
ever, 4 μg/ml exhibited a significant toxicity to cells as
shown in Fig. 1b. Similar pattern was observed with cells
stimulated with anti-CD3 mAb (Fig. 1c). As a result, we
concluded 4 μg/ml as a significantly toxic dose of A.S.
extract to stimulated human PBMCs.
Effect of Allium sativum preparation on PBMC
Proliferation
Subsequently, we tested the effect of the non toxic doses
of A.S. extract on human PBMC proliferation by using
CFSE combined to flow cytometry. To test whether A.S. is
able to induce PBMC (more specifically CD4+ and CD8+
T lymphocytes) proliferation in the absence of mitogenic
stimulation, unstimulated CFSE-labeled PBMCs were
incubated with A.S. preparations at two doses (1 and
2 μg/ml) for 96 h. Our results showed that A.S. did not
affect significantly T lymphocyte proliferation at the non
toxic doses tested (Fig. 2 a, b, c, j, k, l; and Additional file 1:
Figure S1a and c). In order to test whether A.S. is able to
inhibit or enhance PHA or anti-CD3 –stimulated CD4+
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and CD8+ T cells proliferation, CFSE-labeled PBMCs were
stimulated by PHA or anti-CD3 mAb (Okt-3), in the
absence or presence of A.S. extract (Fig. 2 d, e, f, m, n, o, g,
h, i, p, q, r; and Additional file 1: Figure S1 a, b, c et d).
These data showed that A.S. did not affect significantly
CD4+ or CD8+ T lymphocyte proliferation.
Significant regulation of IL-17 gene expression by Allium
sativum
To assess the effect of Allium sativum on pro- and anti-
inflammatory cytokine gene expression, we treated
PBMCs from healthy donors, for 18 h, with non toxic
doses of A.S. preparation with or without PHA stimula-
tion. Results in Fig. 3a indicate that a single treatment
with A.S. extract stimulated significantly the expression of
the pro-inflammatory cytokine, IL-17. We could detect an
increased expression of IL-17 gene in 4 out of 6 donors
tested. In all these 4 donors, we have observed an increase
in IL-17 transcripts upon treatment with A.S.. Interestingly,
when PBMCs were stimulated with PHA, treatment with
A.S. showed a significant and dose dependent decrease in
IL-17 gene expression (Fig. 3b). On the other hand, we
could not detect any statistically significant effect of A.S. on
IL-4 gene expression (known to be an anti-inflammatory
cytokine), either in the absence (Fig. 3c) or presence
(Fig. 3d) of a T lymphocyte activator such as PHA. It is to
note that a trend of increase in IL-4 gene expression was
observed in some donors both in the absence (Fig. 3c) and
the presence (Fig. 3d) of PHA, but this effect was not signifi-
cant. We also tempted to quantify the expression of IFN-γ
gene in our experiments, but we could not detect its expres-
sion in our tested donors (data not shown); and thus no
conclusions could be drawn for this cytokine. Altogether,
these data suggested that A.S. preparation exhibited a signifi-
cant regulation of IL-17 gene expression and that this effect
would depend on the activation state of T lymphocytes.
Analysis of polyphenols and flavonoids in Allium sativum
extract by HPLC
With the aim of identifying the bioactive compounds of
Allium sativum extract responsible for the observed
effect, A.S. ethanolic preparation was analyzed by HPLC
at 285 nm, to determine the presence of polyphenols
and flavonoids. A mixture of seven standards was used
in this experiment. Interestingly, three compounds,
catechin, vanillic acid and ferulic acid, were identified
Fig. 1 Assessment of Allium sativum preparation cytotoxicity on human PBMCs. Human PBMCs were cultured for 4 days in the absence (cntrl-)
or the presence of different doses of Allium sativum extract (a). In another series of experiments, PBMCs were left untreated or were treated with
A.S. extract in the presence of PHA (b) or Okt-3 mAb (c). 4 days later, MTT assay was performed to evaluate cytotoxicity. Experiments shown in
a, b and c are representative of five, five and three independent experiments respectively. Data were analyzed using one way ANOVA test. (*, **)
indicate P values of less than 0.05 and 0.01 respectively
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from the extract by matching their retention time against
those of the standards. Peak assignment was confirmed
by injection of standards. Figure 4a shows the HPLC
chromatogram of a mixture of 7 polyphenol standards
for peak comparison with the chromatogram of the
A.S. extract (Fig. 4b). The HPLC chromatogram of A.S
extract in Fig. 4b displayed 7 peaks detected at 285 nm.
Peaks 1, 2 and 6 were identified as catechin, vanillic acid
and ferulic acid, respectively. The chemical structure
of each of the identified compounds is elucidated in
Fig. 4c.
To summarize, this study showed that A.S. extract
contains compounds, which could be used in non toxic
doses and without affecting T cell proliferation, to
modulate IL-17 gene expression by significantly stimu-
lating its expression in the absence of prior PBMC acti-
vation; and to significantly inhibit its expression when
PBMCs are stimulated with a mitogen such as PHA.
Interestingly, in the same experimental conditions, A.S.
does not affect the expression of the anti-inflammatory
cytokine, IL-4. Furthermore, these data showed that our
A.S. extract contains 3 polyphenol compounds, catechin,
(See figure on previous page.)
Fig. 2 Effect of Allium sativum extract on human PBMCs proliferation. Panels from a to i show an example of data generated by CFSE and anti-CD4
stained PBMCs. Panels from j to r show an example of data generated by CFSE and anti-CD8 stained PBMCs. Cells were cultured in different conditions
of stimulation and treated with two doses of Allium sativum (A.S.) extract for 4 days. a and j untreated PBMCs b and k, c and l PBMCs treated with A.S.
extract at 1 and 2 μg/ml respectively. d and m PBMCs stimulated with PHA. e and n, f and o cells were stimulated with PHA and treated with A.S.
extract at 0.5 and 1 μg/ml respectively. g and p cells were stimulated with Okt-3 mAb at 0.1 μg/ml. h and q, i and r PBMCs stimulated with Okt-3
mAb and treated with A.S. extract at 1 and 2 μg/ml respectively. Each peak represents a cycle of cell division. The curves generated by the CFSE profile
were analyzed using the proliferation platform of the FlowJo software. Data shown represent results of 4 independent experiments. IP indicates index
of proliferation calculated with FlowJo software
Fig. 3 Effects of Allium sativum extract on IL-17 and IL-4 gene expression in PBMCs. IL-17 (a) and IL-4 (c) transcripts were evaluated in PBMCs
treated with two doses of A.S. IL-17 (b) and IL-4 (d) transcripts were assessed in PBMCs stimulated with PHA in the absence or presence of two
doses of A.S.. Data were represented in mean ± S.D. Data were analyzed using the one-way ANOVA test. (*, ***) indicate P values of less than
0.05 and 0.001 respectively. Data shown in a, b, c and d are representative of four, three, five and five independent experiments respectively
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vanillic acid and ferulic acid, which could be responsible
for this potentially interesting effect.
Discussion
For many years, A.S. has been acknowledged as an im-
portant folk medicine with a favorable effect against a
large number of pathologic conditions. In this work, we
aimed to evaluate the potential in vitro immunomodula-
tory effect of A.S., on PBMCs from healthy donors. We
started by defining a range of non toxic doses using the
MTT assay. These doses were used to evaluate cell pro-
liferation and to quantify pro and anti-inflammatory
cytokine gene expression. Our data showed that doses
from 0.5 to 2 μg/ml of A.S. ethanolic extract were not
toxic to cells under any of the used conditions. The
same doses were used to test whether our A.S. extract
exhibited any effect on PBMCs proliferation. Our results
showed that A.S. extract did not affect neither human
CD4+ nor CD8+ T cell proliferation induced by PHA, as
shown by flow cytometry, which is consistent with data
reported by others [16] when cells were stimulated by
PHA. While in the same time, other data showed diver-
gent results. Since Morioka et al. showed that A.S. extract
enhanced ConA-induced proliferation of human T
lymphocytes [16]. Other data revealed that several organo-
sulfur compounds extracted from A.S. displayed a cell
proliferation modulation, such as ajoene that exerted a
strong inhibitory effect on PHA, phorbol myristate acetate
and anti-CD3 mAb -induced proliferation of human
lymphocytes [22, 23]. Colic et al. also demonstrated that
a protein fraction from A.S. aqueous extract exhibited
an enhancement of T-cell proliferation in mouse sple-
nocyte cultures stimulated with PHA. As further ex-
plained in [24, 25], A.S. extracts and their compounds
had a dual role on mice and rat T lymphocyte proli-
feration. In fact, higher concentrations (50 μg/ml)
inhibited T cell proliferation triggered by ConA and at
lower concentrations (3–12.5 μg/ml) of the extract, ampli-
fied the ConA-induced proliferative response of T cells
[25]. It was also well demonstrated that aged A.S. extract
enhanced the proliferation of spleen cells. Aged A.S.
extract slightly improved ConA- induced proliferation of
mice spleen cells, but did not increase the effects of the
other mitogens, pokeweed mitogen (PWM) and lipopo-
lysaccharides (LPS) [26]. This divergence might depend
on different stimulation types, on the cell type used,
and the A.S. preparation method used during these
experiments.
As for cytokine gene expression, we could not detect
any significant effect on IL-4 gene expression. While
previous studies reported an increase in IFN-γ and IL-4
production in lymphocytes from rat spleens upon oral
A.S. consumption [27]; and an increase in IL-4 when
lymphocytes from rat spleens were stimulated by phorbol
Fig. 4 a Chromatogram of 7 available polyphenol and flavonoid standards monitored at 280 nm and identified by retention time (minutes)
1: catechin, 2: vanillic acid, 3: cafeic acid, 4: syringic acid, 5: rutin, 6: ferulic acid, 7: vanillin. b HPLC chromatogram of A.S. extract obtained under
optimum conditions: 88 % water and 12 % acetonitril, 50 min. Peak no. 1: catechin, 2: vanillic acid and 6: ferulic acid were identified. c The
chemical structure of the three identified compounds
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myristate acetate and treated with aqueous and ethanol
preparations made from garlic powder [28]. A.S. powder
extracts were found to reduce the level of pro-inflammatory
cytokines, IL-1β and TNFα, in human blood sample super-
natants, while the expression of the anti-inflammatory cyto-
kine IL-10 was unchanged [29].
Our present study is the first report showing the ability
of A.S. compounds to inhibit IL-17 gene expression. The
present data showed an inhibition of the pro-inflammatory
cytokine, IL-17 gene expression without affecting the anti-
inflammatory cytokine IL-4, which might suggest a specific
potential regulation of IL-17 that could be useful in control-
ling several inflammatory and autoimmune diseases, such
as multiple sclerosis, rheumatoid arthritis and cancer. For
example, it was shown that IL-17 plays a pivotal role in the
development of central nervous system inflammation in
multiple sclerosis, where it was found to correlate with
active lesions [30] and to be up-regulated in chronic lesions
in multiple sclerosis patients [31, 32]. IL-17 was also shown
to be involved in the pathogenesis of rheumatoid arthritis
[33]. Indeed, a high level of IL-17 was found in synovium
and synovial cultures from rheumatoid arthritis patients
[34, 35]. IL-17 appeared to activate and enhance all mecha-
nisms of tissue injury and to up-regulate and/or synergize
with local inflammatory mediators such as IL-6 [36, 37],
IL-1β and TNF-α [37, 38]. Furthermore, there are sugges-
tions that in pulmonary asthma there are higher levels
of intracellular IL-17 and increased numbers of IL-17-
producing cells (T lymphocytes and eosinophils in
broncheoalveolar lavage) relative to healthy controls both
locally and within the circulation [39]. Higher amounts of
IL-17 has also been revealed in many different types of
human tumors including lymphoma, melanoma, breast,
colon, gastric, hepatocellular, pancreatic, ovarian and pros-
tate cancers. Overall, the presence of Th17 cells and/or
IL-17 has been reported to be a poor prognostic indi-
cator [40]. Similar observations have also been made
in different mouse models of cancer [40]. Wilke et al.
explained how IL-17 has become an interesting thera-
peutic target in many autoimmune diseases [41].
Because there is an ongoing debate concerning whether
organosulfur compounds or other constituents such as
polyphenols and flavonoids, mediate the protective effect
attributed to garlic [29], we carried out a qualitative
analysis of the A.S. extract by HPLC. This showed the
presence of two phenolic acids “vanillic acid and ferulic
acid” and a flavonoid of the flavonols class which is
“catechin”. These phenolic compounds are known to have
interesting immunomodulatory effects but none of them
was tested on the expression of IL-17 from human PBMC.
Vanillic acid, which is a benzoic acid derivative and an
oxidized form of vanillin formed during the transfor-
mation of vanillin to ferulic acid [42–44], has been proved
to enhance the activity of lymphocyte proliferation and
IFN-γ secretion in human PBMCs [45] and to exhibit a
hepatoprotective effect by its suppressive action on immune-
mediated liver inflammation in ConA-induced liver injury
in mouse [44, 46]. As for ferulic acid, it was found to have
a chemopreventive activity against coronary heart disease,
thrombosis, mutagenesis and carcinogenesis, in addition
to an anti-cancer activity against colon and rectal cancer
[47]. Catechin is a major compound of flavonoids, which
are known for their ability to control lymphocyte prolifer-
ation and to modulate IL-2 and IFN-γ secretion in human
PBMCs and mouse splenocytes [48]. It was also found that
catechin ameliorates cardiac dysfunction, in a rat model of
chronic heart failure, by regulating the unbalanced level of
IL-17/IL-10 [49].
Conclusion
Allium sativum L. preparation exhibiting a specific in-
hibition of the pro-inflammatory cytokine IL-17, without
affecting cell proliferation in human PBMCs indicates a
potential valuable effect of the compounds present in
this plant to treat inflammatory diseases and cancer,
where IL-17 is highly involved. The individual contribu-
tion of these identified compounds to this interesting
global inhibitory effect is under investigation and could
unravel a pivotal therapeutic role.
Additional files
Additional file 1: Figure S1. Effect of Allium sativum extract on human
PBMC proliferation. CD4 T cell division was evaluated by CFSE staining
and flow cytometry when PBMCs were treated with or without A.S. at
two different doses in the absence or presence of PHA (a) or Okt-3 mAb
(b). CD8 T cell division assessed by CFSE staining and flux cytometry
within PBMCs treated with or without A.S. at two doses in the absence or
presence of PHA (c) or Okt-3 mAb (d). Data shown are representative of
4 independent experiments. Percentage of cell division was calculated
with FlowJo software. Data are represented in mean ± S.D. and were
analyzed using the one-way ANOVA test. (DOCX 278 kb)
Additional file 2: Raw data of MTT assays. (XLSX 10 kb)
Additional file 3: Raw data of cell proliferation using flow cytometry.
(XLSX 14 kb)
Additional file 4: Raw data of gene expression by real time RTPCR.
(XLSX 17 kb)
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